Marshall Wace’s OneMedNet ONMD Stock Holding History

Marshall Wace’s Portfolio ONMD Stock Details ONMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-28,754	Closed	-$298K	–	3289
2022 Q3	$298K	Hold	28,754	–	–	﹤0.01%	2954
2022 Q2	$295K	Hold	28,754	–	–	﹤0.01%	3036
2022 Q1	$292K	Hold	28,754	–	–	﹤0.01%	2973
2021 Q4	$291K	Hold	28,754	–	–	﹤0.01%	3045
2021 Q3	$289K	Buy	+28,754	New	+$287K	﹤0.01%	2664

Other funds holding ONMD

WCMNY

Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return

SCM

Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return

OCAM

Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return

Meteora Capital Boca Raton, Florida $1.36B AUM 21.19% 1-Year Est. Return

Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

KIM LLC Wichita, Kansas $976M AUM 0.91% 1-Year Est. Return

WRBC

W.R. Berkley Corp Greenwich, Connecticut $1.86B AUM 14.44% 1-Year Est. Return

SIA

SkyView Investment Advisors Shrewsbury, New Jersey $743M AUM 17.91% 1-Year Est. Return

Marshall Wace's ONMD Position: Q4 2022 in Review

Marshall Wace sold out of OneMedNet (ONMD) in Q4 2022, closing a stake of 28,754 shares — an estimated $298K sold.

Marshall Wace first reported a position in ONMD in Q3 2021 and held it in 5 quarters. The position peaked at $298K in Q3 2022. 18 funds tracked by Wall St. Rank hold ONMD as of Q4 2022.

Marshall Wace reported no remaining OneMedNet position as of Q4 2022 after selling out during the quarter.
Marshall Wace sold 28,754 OneMedNet shares in Q4 2022, an estimated $298K.
Marshall Wace first reported a position in OneMedNet in Q3 2021 and held it in 5 quarters.
Marshall Wace's OneMedNet position peaked at $298K in Q3 2022.
18 funds tracked by Wall St. Rank held OneMedNet as of Q4 2022.

Based on Marshall Wace's 13F filing for Q4 2022, filed 14 Feb 2023.